Read + Share
Xu J, Bai Y, Sun H, Bai C, et al. A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients
with unresectable or metastatic biliary tract cancer. Cancer 2021 Aug 6. doi: 10.1002/cncr.33803.
PMID: 34355801
|
 |
|
Xu J, Bai Y, Sun H, Bai C, et al. A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients
with unresectable or metastatic biliary tract cancer. Cancer 2021 Aug 6. doi: 10.1002/cncr.33803.
PMID: 34355801
|
|
|
|